召回-话题@MedSci

#召回#

50篇内容 | 2148人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1489265, encodeId=7f77148926546, content=<a href='/topic/show?id=fde43840491' target=_blank style='color:#2F92EE;'>#召回#</a>, objectTitle=缬沙坦全球召回事件已波及日本全球或迎来降压药短缺, objectType=article, longId=160836, objectId=e90c160836b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e90c160836b3, replyNumber=0, likeNumber=79, createdTime=2019-02-24, rootId=0, userName=doctorzheng, userId=1df18514500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e90c160836b3, moduleTitle=缬沙坦全球召回事件已波及日本全球或迎来降压药短缺, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e90c160836b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489264, encodeId=771f1489264de, content=<a href='/topic/show?id=fde43840491' target=_blank style='color:#2F92EE;'>#召回#</a>, objectTitle=致癌物含量超标，Aurobindo正在美国召回近50万瓶抗血压药, objectType=article, longId=159102, objectId=398a15910200, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=398a15910200, replyNumber=0, likeNumber=69, createdTime=2019-01-30, rootId=0, userName=doctorzheng, userId=1df18514500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=398a15910200, moduleTitle=致癌物含量超标，Aurobindo正在美国召回近50万瓶抗血压药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=398a15910200)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489263, encodeId=b71f148926349, content=<a href='/topic/show?id=fde43840491' target=_blank style='color:#2F92EE;'>#召回#</a>, objectTitle=紧急公告：这个注射液全国停用、召回, objectType=article, longId=157133, objectId=430f15e13379, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=430f15e13379, replyNumber=0, likeNumber=69, createdTime=2019-01-02, rootId=0, userName=doctorzheng, userId=1df18514500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=430f15e13379, moduleTitle=紧急公告：这个注射液全国停用、召回, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=430f15e13379)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489262, encodeId=ca011489262ab, content=<a href='/topic/show?id=fde43840491' target=_blank style='color:#2F92EE;'>#召回#</a>, objectTitle=深度学习中评价指标：准确率、**率、召回率、 F-1 Score、ROC、AUC、MAE, objectType=article, longId=154990, objectId=d965154990aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d965154990aa, replyNumber=0, likeNumber=71, createdTime=2018-12-04, rootId=0, userName=doctorzheng, userId=1df18514500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d965154990aa, moduleTitle=深度学习中评价指标：准确率、**率、召回率、 F-1 Score、ROC、AUC、MAE, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d965154990aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489261, encodeId=8f9b148926120, content=<a href='/topic/show?id=fde43840491' target=_blank style='color:#2F92EE;'>#召回#</a>, objectTitle=国家药监局：对47批次不合规药品已查封扣押，要求停售召回, objectType=article, longId=152731, objectId=feb4152e31bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=feb4152e31bc, replyNumber=0, likeNumber=80, createdTime=2018-11-05, rootId=0, userName=doctorzheng, userId=1df18514500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=feb4152e31bc, moduleTitle=国家药监局：对47批次不合规药品已查封扣押，要求停售召回, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=feb4152e31bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489260, encodeId=8c3a148926003, content=<a href='/topic/show?id=fde43840491' target=_blank style='color:#2F92EE;'>#召回#</a>, objectTitle=在缬沙坦召回事件1年多前，FDA已经发现了华海药业的生产问题, objectType=article, longId=146507, objectId=d1fc14650ed6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1fc14650ed6, replyNumber=0, likeNumber=95, createdTime=2018-08-14, rootId=0, userName=doctorzheng, userId=1df18514500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1fc14650ed6, moduleTitle=在缬沙坦召回事件1年多前，FDA已经发现了华海药业的生产问题, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1fc14650ed6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489259, encodeId=d63f1489259ef, content=<a href='/topic/show?id=fde43840491' target=_blank style='color:#2F92EE;'>#召回#</a>, objectTitle=关于医疗器械的“召回”，你还应该了解这些, objectType=article, longId=145926, objectId=4d8f1459267e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d8f1459267e, replyNumber=0, likeNumber=88, createdTime=2018-08-06, rootId=0, userName=doctorzheng, userId=1df18514500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d8f1459267e, moduleTitle=关于医疗器械的“召回”，你还应该了解这些, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d8f1459267e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489258, encodeId=4d89148925839, content=<a href='/topic/show?id=fde43840491' target=_blank style='color:#2F92EE;'>#召回#</a>, objectTitle=5类高血压常用药被召回，所有医疗机构停用！, objectType=article, longId=145925, objectId=b65314592561, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b65314592561, replyNumber=0, likeNumber=77, createdTime=2018-08-06, rootId=0, userName=doctorzheng, userId=1df18514500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b65314592561, moduleTitle=5类高血压常用药被召回，所有医疗机构停用！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b65314592561)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489257, encodeId=3460148925eba, content=<a href='/topic/show?id=fde43840491' target=_blank style='color:#2F92EE;'>#召回#</a>, objectTitle=医疗器械召回，国产数量在增多, objectType=article, longId=144917, objectId=1be714491eda, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1be714491eda, replyNumber=0, likeNumber=71, createdTime=2018-07-23, rootId=0, userName=doctorzheng, userId=1df18514500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1be714491eda, moduleTitle=医疗器械召回，国产数量在增多, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1be714491eda)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489256, encodeId=a6b71489256a7, content=<a href='/topic/show?id=fde43840491' target=_blank style='color:#2F92EE;'>#召回#</a>, objectTitle=Radiology：筛查乳腺X线摄影召回率随数字乳腺断层合成应用的变化而变化吗？, objectType=article, longId=140307, objectId=744314030e74, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=744314030e74, replyNumber=0, likeNumber=65, createdTime=2018-06-09, rootId=0, userName=doctorzheng, userId=1df18514500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=744314030e74, moduleTitle=Radiology：筛查乳腺X线摄影召回率随数字乳腺断层合成应用的变化而变化吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=744314030e74)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489255, encodeId=839a148925501, content=<a href='/topic/show?id=fde43840491' target=_blank style='color:#2F92EE;'>#召回#</a>, objectTitle=召回不可怕可怕的是不召回, objectType=article, longId=128257, objectId=787012825e50, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=787012825e50, replyNumber=0, likeNumber=71, createdTime=2018-02-01, rootId=0, userName=doctorzheng, userId=1df18514500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=787012825e50, moduleTitle=召回不可怕可怕的是不召回, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=787012825e50)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489254, encodeId=a60e1489254f7, content=<a href='/topic/show?id=fde43840491' target=_blank style='color:#2F92EE;'>#召回#</a>, objectTitle=由Auromedics Pharma的Linezolid注射液:自愿召回600mg / 300mL软袋-由于存在白色颗粒物质，已被鉴定为霉菌, objectType=article, longId=125014, objectId=b95e12501434, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b95e12501434, replyNumber=0, likeNumber=71, createdTime=2017-12-30, rootId=0, userName=doctorzheng, userId=1df18514500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b95e12501434, moduleTitle=由Auromedics Pharma的Linezolid注射液:自愿召回600mg / 300mL软袋-由于存在白色颗粒物质，已被鉴定为霉菌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b95e12501434)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489253, encodeId=798a148925393, content=<a href='/topic/show?id=fde43840491' target=_blank style='color:#2F92EE;'>#召回#</a>, objectTitle=蓝珍珠全天然男性增强补充剂召回, objectType=article, longId=123620, objectId=64e212362081, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64e212362081, replyNumber=0, likeNumber=68, createdTime=2017-12-17, rootId=0, userName=doctorzheng, userId=1df18514500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64e212362081, moduleTitle=蓝珍珠全天然男性增强补充剂召回, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64e212362081)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489252, encodeId=0c72148925265, content=<a href='/topic/show?id=fde43840491' target=_blank style='color:#2F92EE;'>#召回#</a>, objectTitle=医疗器械召回：何必谈虎色变, objectType=article, longId=116295, objectId=f836116295d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f836116295d2, replyNumber=0, likeNumber=84, createdTime=2017-10-17, rootId=0, userName=doctorzheng, userId=1df18514500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f836116295d2, moduleTitle=医疗器械召回：何必谈虎色变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f836116295d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489251, encodeId=e85d1489251c6, content=<a href='/topic/show?id=fde43840491' target=_blank style='color:#2F92EE;'>#召回#</a>, objectTitle=喜炎平被召回，中药注射液还能不能用？, objectType=article, longId=114558, objectId=cc5211455860, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc5211455860, replyNumber=0, likeNumber=56, createdTime=2017-09-29, rootId=0, userName=doctorzheng, userId=1df18514500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc5211455860, moduleTitle=喜炎平被召回，中药注射液还能不能用？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc5211455860)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489250, encodeId=05c11489250b8, content=<a href='/topic/show?id=fde43840491' target=_blank style='color:#2F92EE;'>#召回#</a>, objectTitle=食药监总局责令两药企立即召回红花、喜炎平注射液, objectType=article, longId=114031, objectId=e93b11403139, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e93b11403139, replyNumber=0, likeNumber=74, createdTime=2017-09-26, rootId=0, userName=doctorzheng, userId=1df18514500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e93b11403139, moduleTitle=食药监总局责令两药企立即召回红花、喜炎平注射液, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e93b11403139)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489249, encodeId=79801489249ae, content=<a href='/topic/show?id=fde43840491' target=_blank style='color:#2F92EE;'>#召回#</a>, objectTitle=因安全漏洞美国FDA召回465000个心脏起搏器, objectType=article, longId=111940, objectId=bf6d111940b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf6d111940b4, replyNumber=0, likeNumber=60, createdTime=2017-09-06, rootId=0, userName=doctorzheng, userId=1df18514500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf6d111940b4, moduleTitle=因安全漏洞美国FDA召回465000个心脏起搏器, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf6d111940b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489248, encodeId=62041489248dc, content=<a href='/topic/show?id=fde43840491' target=_blank style='color:#2F92EE;'>#召回#</a>, objectTitle=医械企业注意！《医疗器械召回管理办法》已正式生效, objectType=article, longId=97824, objectId=1baa9e8249e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1baa9e8249e, replyNumber=0, likeNumber=61, createdTime=2017-05-05, rootId=0, userName=doctorzheng, userId=1df18514500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1baa9e8249e, moduleTitle=医械企业注意！《医疗器械召回管理办法》已正式生效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1baa9e8249e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489247, encodeId=9097148924ed5, content=<a href='/topic/show?id=fde43840491' target=_blank style='color:#2F92EE;'>#召回#</a>, objectTitle=新规落地：不合格医疗器械全部召回重大缺陷药企担责, objectType=article, longId=97763, objectId=9af09e76366, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9af09e76366, replyNumber=0, likeNumber=95, createdTime=2017-05-04, rootId=0, userName=doctorzheng, userId=1df18514500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9af09e76366, moduleTitle=新规落地：不合格医疗器械全部召回重大缺陷药企担责, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9af09e76366)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489246, encodeId=45141489246e1, content=<a href='/topic/show?id=fde43840491' target=_blank style='color:#2F92EE;'>#召回#</a>, objectTitle=“孤儿药”被召回致市场断供，多地重症肌无力患者一药难求, objectType=article, longId=84513, objectId=6b4a845138d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b4a845138d, replyNumber=0, likeNumber=76, createdTime=2016-12-18, rootId=0, userName=doctorzheng, userId=1df18514500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b4a845138d, moduleTitle=“孤儿药”被召回致市场断供，多地重症肌无力患者一药难求, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b4a845138d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

召回

2020-05-29

doctorzheng (审核中...)

前往app查看评论内容

#召回#

缬沙坦全球召回事件已波及日本全球或迎来降压药短缺

2019-02-24

doctorzheng (审核中...)

前往app查看评论内容

#召回#

致癌物含量超标，Aurobindo正在美国召回近50万瓶抗血压药

2019-01-30

doctorzheng (审核中...)

前往app查看评论内容

#召回#

紧急公告：这个注射液全国停用、召回

2019-01-02

doctorzheng (审核中...)

前往app查看评论内容

#召回#

深度学习中评价指标：准确率、**率、召回率、 F-1 Score、ROC、AUC、MAE

2018-12-04

doctorzheng (审核中...)

前往app查看评论内容

#召回#

国家药监局：对47批次不合规药品已查封扣押，要求停售召回

2018-11-05

doctorzheng (审核中...)

前往app查看评论内容

#召回#

在缬沙坦召回事件1年多前，FDA已经发现了华海药业的生产问题

2018-08-14

doctorzheng (审核中...)

前往app查看评论内容

#召回#

关于医疗器械的“召回”，你还应该了解这些

2018-08-06

doctorzheng (审核中...)

前往app查看评论内容

#召回#

5类高血压常用药被召回，所有医疗机构停用！

2018-08-06

doctorzheng (审核中...)

前往app查看评论内容

#召回#

医疗器械召回，国产数量在增多

2018-07-23

doctorzheng (审核中...)

前往app查看评论内容

#召回#

Radiology：筛查乳腺X线摄影召回率随数字乳腺断层合成应用的变化而变化吗？

2018-06-09

doctorzheng (审核中...)

前往app查看评论内容

#召回#

召回不可怕可怕的是不召回

2018-02-01

doctorzheng (审核中...)

前往app查看评论内容

#召回#

由Auromedics Pharma的Linezolid注射液:自愿召回600mg / 300mL软袋-由于存在白色颗粒物质，已被鉴定为霉菌

2017-12-30

doctorzheng (审核中...)

前往app查看评论内容

#召回#

蓝珍珠全天然男性增强补充剂召回

2017-12-17

doctorzheng (审核中...)

前往app查看评论内容

#召回#

医疗器械召回：何必谈虎色变

2017-10-17

doctorzheng (审核中...)

前往app查看评论内容

#召回#

喜炎平被召回，中药注射液还能不能用？

2017-09-29

doctorzheng (审核中...)

前往app查看评论内容

#召回#

食药监总局责令两药企立即召回红花、喜炎平注射液

2017-09-26

doctorzheng (审核中...)

前往app查看评论内容

#召回#

因安全漏洞美国FDA召回465000个心脏起搏器

2017-09-06

doctorzheng (审核中...)

前往app查看评论内容

#召回#

医械企业注意！《医疗器械召回管理办法》已正式生效

2017-05-05

doctorzheng (审核中...)

前往app查看评论内容

#召回#

新规落地：不合格医疗器械全部召回重大缺陷药企担责

2017-05-04

doctorzheng (审核中...)

前往app查看评论内容

#召回#

“孤儿药”被召回致市场断供，多地重症肌无力患者一药难求

2016-12-18

科室
- - 订阅+
  - 更多科室
工具
服务